JNBA Financial Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91.2K Sell
422
-174
-29% -$33.3K 0.01% 255
2026
Q1
$109K Hold
596
0.01% 227
2025
Q4
$105K Sell
596
-30
-5% -$4.9K 0.01% 235
2025
Q3
$87.7K Hold
626
0.01% 246
2025
Q2
$78.6K Hold
626
0.01% 249
2025
Q1
$85.7K Sell
626
-240
-28% -$34.3K 0.01% 230
2024
Q4
$132K Sell
866
-150
-15% -$25.3K 0.01% 194
2024
Q3
$197K Sell
1,016
-55
-5% -$11.5K 0.02% 184
2024
Q2
$248K Hold
1,071
0.03% 173
2024
Q1
$231K Sell
1,071
-201
-16% -$47.1K 0.02% 180
2023
Q4
$329K Hold
1,272
0.04% 162
2023
Q3
$327K Buy
1,272
+191
+18% +$51.1K 0.04% 158
2023
Q2
$308K Sell
1,081
-5
-0.5% -$1.49K 0.04% 166
2023
Q1
$302K Hold
1,086
0.04% 165
2022
Q4
$301K Hold
1,086
0.04% 158
2022
Q3
$290K Hold
1,086
0.04% 158
2022
Q2
$221K Sell
1,086
-135
-11% -$27.6K 0.03% 172
2022
Q1
$257K Sell
1,221
-25
-2% -$5.44K 0.03% 171
2021
Q4
$299K Sell
1,246
-5
-0.4% -$1.29K 0.04% 167
2021
Q3
$354K Hold
1,251
0.05% 149
2021
Q2
$433K Sell
1,251
-185
-13% -$56K 0.06% 132
2021
Q1
$402K Hold
1,436
0.06% 133
2020
Q4
$352K Sell
1,436
-65
-4% -$16.8K 0.06% 131
2020
Q3
$426K Hold
1,501
0.09% 102
2020
Q2
$402K Sell
1,501
-75
-5% -$22.5K 0.09% 106
2020
Q1
$499K Sell
1,576
-10
-0.6% -$3.04K 0.12% 88
2019
Q4
$471K Hold
1,586
0.09% 102
2019
Q3
$369K Sell
1,586
-159
-9% -$37K 0.08% 107
2019
Q2
$408K Buy
1,745
+440
+34% +$102K 0.08% 106
2019
Q1
$308K Sell
1,305
-25
-2% -$7.87K 0.07% 115
2018
Q4
$400K Buy
1,330
+905
+213% +$289K 0.09% 96
2018
Q3
$150K Sell
425
-1,030
-71% -$355K 0.07% 148
2018
Q2
$422K Hold
1,455
0.09% 94
2018
Q1
$398K Sell
1,455
-25
-2% -$7.76K 0.09% 92
2017
Q4
$471K Sell
1,480
-15
-1% -$4.81K 0.1% 85
2017
Q3
$468K Hold
1,495
0.1% 77
2017
Q2
$406K Buy
1,495
+30
+2% +$7.93K 0.09% 81
2017
Q1
$401K Buy
1,465
+14
+1% +$3.96K 0.09% 80
2016
Q4
$411K Buy
1,451
+486
+50% +$144K 0.1% 77
2016
Q3
$302K Sell
965
-456
-32% -$135K 0.04% 162
2016
Q2
$344K Buy
1,421
+405
+40% +$107K 0.1% 78
2016
Q1
$264K Buy
1,016
+85
+9% +$22.5K 0.1% 85
2015
Q4
$285K Buy
931
+195
+26% +$56K 0.11% 83
2015
Q3
$215K Buy
736
+700
+1,944% +$231K 0.09% 91
2015
Q2
$15K Hold
36
0.01% 312
2015
Q1
$15K Hold
36
0.01% 324
2014
Q4
$12K Hold
36
﹤0.01% 340
2014
Q3
$12K Buy
+36
New +$11.9K 0.01% 350

Other funds holding BIIB

JNBA Financial Advisors's BIIB Position: Q2 2026 in Review

JNBA Financial Advisors reduced its Biogen (BIIB) stake by 29% in Q2 2026, selling an estimated $33.3K and leaving 422 shares worth $91.2K. The position accounts for 0.01% of the portfolio, ranked #255.

JNBA Financial Advisors first reported a position in BIIB in Q3 2014 and has held it in 48 quarters since. The position peaked at $499K in Q1 2020. 301 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • JNBA Financial Advisors held 422 shares of Biogen worth $91.2K as of Q2 2026.
  • JNBA Financial Advisors sold 174 Biogen shares in Q2 2026, an estimated $33.3K.
  • Biogen made up 0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #255 holding.
  • JNBA Financial Advisors first reported a position in Biogen in Q3 2014 and has held it in 48 quarters since.
  • JNBA Financial Advisors's Biogen position peaked at $499K in Q1 2020.
  • 301 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.